[1]
“Use of Sodium–Glucose Cotransporter 2 (SGLT-2) Inhibitors Beyond Diabetes: On the Verge of a Paradigm Shift?”, Rhythmos, vol. 15, no. 1, pp. 1–5, Jan. 2020, Accessed: May 03, 2025. [Online]. Available: https://www.rhythmos.gr/index.php/Rhythmos/article/view/473